FDA Inspection 1242664 — DSG Biotec GmbH Institut fur Pharma-Analytik
The FDA completed an inspection of DSG Biotec GmbH Institut fur Pharma-Analytik on May 24, 2023 in Aschau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 24, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aschau (Germany)
Additional Details
Mutual Recognition Agreement (MRA)